Business
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET
DALLAS, May 08, 2025--Q1 Earnings Call Save The Date
About this update from Lantern Pharma Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/e7d413287ef26b642b38cad24271668a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OGykR6gtUPXYYhEOjiSNVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e7d413287ef26b642b38cad24271668a","width":480,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Webcast to be held Thursday, May 15th, 9:00 a.m. ET, register for the webcast here, or at the link provided below.","length":114,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":114,"olType":false},{"type":"text","content":"DALLAS, May 08, 2025--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning ("ML") platform with multiple clinical stage drug programs, today announced that it will host its first quarter 2025 operating and financial results webcast on Thursday, May 15, 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.","length":471,"tagName":"p"},{"type":"text","content":"Management intends to discuss the operating and financial results for the first quarter ended March 31, 2025 and provide guidance on upcoming milestones, clinical trials and developments of the AI platform, RADR®. Panna Sharma, President and Chief Executive Officer of Lantern Pharma, will lead the call and will be joined by other members of the management team.","length":363,"tagName":"p"},{"type":"text","content":"To register for the webinar, please sign up at the Zoom webcast link provided in the link: Lantern Pharma Q1, 2025 earnings Zoom webcast registration link. A replay of the earnings call webcast will be available after the call on the investor relations section of the Company's website: ir.lanternpharma.com.","length":312,"tagName":"p"},{"type":"text","content":"About Lantern Pharma","length":20,"tagName":"p"},{"type":"text","content":"Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®...